Acute angioedema: Recognition and management in the emergency department

European Journal of Emergency Medicine

Volumn 20, Issue 1, 2013, Pages 10-17

  Jaiganesh, Thiagarajan ^a   Wiese, Martin ^c   Hollingsworth, John ^d   Hughan, Chris ^b   Kamara, Mohamed ^e   Wood, Philip ^f   Bethune, Claire ^g  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b Primary Immunodeficiency Association   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e FAIRFIELD GENERAL HOSPITAL   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Angioedema; Bradykinin; Emergency; Swelling; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AIRWAY CONSTRICTION; ANAMNESIS; ANGIONEUROTIC EDEMA; CLINICAL EXAMINATION; EMERGENCY WARD; HUMAN; MAST CELL DEGRANULATION; PRIORITY JOURNAL; REVIEW; SHOCK; SWELLING; URTICARIA;

ACUTE DISEASE; AIRWAY OBSTRUCTION; ALGORITHMS; ANGIOEDEMA; ANGIOEDEMAS, HEREDITARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; CELL DEGRANULATION; EMERGENCY SERVICE, HOSPITAL; HUMANS; LARYNGEAL DISEASES; MAST CELLS; VASODILATOR AGENTS;

EID: 84872201011     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e328356f76e     Document Type: Review

References (44)

1. Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol 2008; 101:185-192.
2. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: Role of bradykinin. Allergy 2007; 62:842-856. (Pubitemid 47037860)
3. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008; 359:1027-1036.
4. Grigoriadou S, Longhurst HJ. Clinical immunology review series: An approach to the patient with angio-oedema. Clin Exp Immunol 2009; 155:367-377.
5. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002; 346:175-179. (Pubitemid 34438884)
6. Burgdorff T, Douwes KE, Bogenrieder T, Szeimies RM, Hohenleutner U, Landthaler M, et al. Superior vena cava syndrome: An important differential diagnosis in patients with facial edema. Acta Derm Venereol 2001; 81:205-206. (Pubitemid 32800468)
7. Kim H, Fischer D. Anaphylaxis. Allergy Asthma Clin Immunol 2011; 7 (Suppl 1):S6.
8. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr., Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: Summary report Y Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-397. (Pubitemid 43190153)
9. Morrow JD, Margolies GR, Rowland J, Roberts LJ II. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 1991; 324:716-720.
10. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-131.
11. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-1697. (Pubitemid 28254530)
12. Ulmer JL, Garvey MJ. Fatal angioedema associated with lisinopril. Ann Pharmacother 1992; 26:1245-1246.
13. Orr KK, Myers Jr. Intermittent visceral edema induced by long-term enalapril administration. Ann Pharmacother 2004; 38:825-827. (Pubitemid 38509062)
14. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 2005; 139:379-394. (Pubitemid 40333248)
15. Prada AE, Zahedi K, Davis AE III. Regulation of C1 inhibitor synthesis. Immunobiology 1998; 199:377-388. (Pubitemid 28404357)
16. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 1976; 84:580-593.
17. Visy B, Fust G, Bygum A, Bork K, Longhurst H, Bucher C, et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter 2007; 12:251-257. (Pubitemid 46701095)
18. Prematta MJ, Kemp JG, Gibbs JG, Mende C, Rhoads C, Craig TJ. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc 2009; 30:506-511.
19. Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol 2010; 6:14-18.
20. Morwood K, Gillis D, Smith W, Kette F. Aspirin-sensitive asthma. Intern Med J 2005; 35:240-246. (Pubitemid 40529586)
21. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310:1621-1626. (Pubitemid 14108873)
22. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, et al. Angioedema without urticaria: A large clinical survey. CMAJ 2006; 175:1065-1070. (Pubitemid 44683294)
23. Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81:1400-1433.
24. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactionsYguidelines for healthcare providers. Resuscitation 2008; 77:157-169.
25. Emergency Cardiovascular Care Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10.6: Anaphylaxis. Circulation 2005; 112:IV-143YIV-145.
26. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24:599-606.
27. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316:1622-1626. (Pubitemid 17082588)
28. Jaiganesh T, Hughan C, Webster A, Bethune C. Hereditary angioedema: A survey of UK emergency departments and recommendations for management. Eur J Emerg Med 2011[Epub ahead of print] doi: 10.1097/MEJ.0b013e32834c9e1f.
29. Kaplan AP. Chronic urticaria: Pathogenesis and treatment. J Allergy Clin Immunol 2004; 114:465-474. (Pubitemid 39194914)
30. Winters M. Clinical Practice Guideline: Initial evaluation and management of patients presenting with acute urticaria or angioedema. American Association of Emergency Medicine, 10 July 2006. Available at: http://www.aaem.org/ positionstatements/clinical-practice-guidelines.php [Accessed 2 February 2012].
31. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. BSACI guidelines for the management of chronic urticaria and angiooedema. Clin Exp Allergy 2007; 37:631-650. (Pubitemid 46643051)
32. Summary of product characteristics: Cetirizine hydrochloride 10mg tablets, 18 July 2009. Available at: http://www.medicines.org.uk/emc/medicine/ 22607/SPC/cetirizine%20hydrochloride%2010mg%20tablets/# POSOLOGY [Accessed 2 February 2012].
33. Waserman S, Chad Z, Francoeur MJ, Small P, Stark D, Vander Leek TK, et al. Management of anaphylaxis in primary care: Canadian expert consensus recommendations. Allergy 2010; 65:1082-1092.
34. McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: What is the evidence? BMJ 2003; 327:1332-1335. (Pubitemid 37510459)
35. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: Outcome after switching to a different treatment. Arch Intern Med 2004; 164:910-913. (Pubitemid 38520634)
36. Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin- converting enzyme inhibitors: A case series. Ann Emerg Med 2010; 56:278-282.
37. Amelioration of angiotensin-converting enzyme inhibitor induced angioedema study. Ref. NCT01154361, 4 March 2011. Available at: http://clinicaltrials.gov [Accessed 21 April 2011].
38. Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtulowicz K, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009; 124:801-808.
39. Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010; 363:513-522.
40. Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S, et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 2010; 126:821-827.
41. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6:24-36.
42. Cicardi M, Banerji A, Bracho F, Malbran A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363:532-541.
43. Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, et al. Randomized placebo-controlled trial of the bradykinin B receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial. Ann Allergy Asthma Immunol 2011; 107:529-537.
44. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 2003; 82:274-281. (Pubitemid 36859223)